MoneyWorks4Me

Lupin informs about disclosure

05 May 2023 Evaluate
Lupin has informed that as approved by the Nomination and Remuneration Committee, on May 4, 2023, the Company granted stock options aggregating 13953 to employees of an overseas subsidiary of the Company, at the exercise price of 2.00 each, under Lupin Subsidiary Companies Employees Stock Option Plan 2014. Upon vesting, one stock option entitles the grantee to subscribe to one equity share of the Company of Rs 2.00 each. The vesting schedule of the options will be 25%:25%:25%:25% over four years upon completion of one year from the date of grant, which is May 4, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..